Innate Pharma SA Financial Assets
Innate Pharma SA (IPHA) had Financial Assets of EUR 57.42 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:FinancialAssets · last filed 2026-04-01
- 2025-12-31: Financial Assets 57.42M EUR.
- 2025-06-30: Financial Assets 87.40M EUR.
- 2024-12-31: Financial Assets 105.35M EUR.
- 2024-06-30: Financial Assets 136.42M EUR.
| Period end | Financial Assets |
|---|---|
| 2025-12-31 | 57.42M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 87.40M EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 105.35M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 136.42M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 168.36M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 181.13M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 189.05M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 219.69M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 207.96M EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 204.52M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 242.21M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 291.35M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 354.82M EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 197.99M EUR 20-F · filed 2020-04-24 |